Cargando…

Dosing study of esmolol for reducing hemodynamic changes during lightwand intubation

BACKGROUND: Lightwand is a convenient tool that can be used instead of a laryngoscope for intubation. Tracheal intubation causes direct stimulation of the larynx, drastically increasing hemodynamic values including blood pressure and heart rate. This study aims to identify the effect of different do...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Jin Ku, Yoo, Sie Hyeon, Chung, Jin Hun, Kim, Nan Seol, Jung, Ho Soon, Seo, Yong Han, Chun, Hea Rim, Gong, Hyung Yoon, Son, Hee Dong, Kim, A Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Anesthesiologists 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724119/
https://www.ncbi.nlm.nih.gov/pubmed/33329844
http://dx.doi.org/10.17085/apm.19067
_version_ 1783620483756851200
author Kang, Jin Ku
Yoo, Sie Hyeon
Chung, Jin Hun
Kim, Nan Seol
Jung, Ho Soon
Seo, Yong Han
Chun, Hea Rim
Gong, Hyung Yoon
Son, Hee Dong
Kim, A Joo
author_facet Kang, Jin Ku
Yoo, Sie Hyeon
Chung, Jin Hun
Kim, Nan Seol
Jung, Ho Soon
Seo, Yong Han
Chun, Hea Rim
Gong, Hyung Yoon
Son, Hee Dong
Kim, A Joo
author_sort Kang, Jin Ku
collection PubMed
description BACKGROUND: Lightwand is a convenient tool that can be used instead of a laryngoscope for intubation. Tracheal intubation causes direct stimulation of the larynx, drastically increasing hemodynamic values including blood pressure and heart rate. This study aims to identify the effect of different doses of esmolol on hemodynamic changes during lightwand intubation. METHODS: The study subjects included 140 patients who underwent general anesthesia for elective surgery. The patients were randomly divided into four groups (35 patients in each group). The ‘C’ group only received 20 ml of normal saline, while the ‘E0.5’, ‘E1’, and ‘E2’ groups received 20 ml of normal saline containing esmolol—0.5 mg/kg, 1 mg/kg, and 2 mg/kg, respectively, injected 2 min prior to intubation. The patients’ blood pressure, heart rate, and rate-pressure product were measured six times, before and after the intubation. RESULTS: The degree of heart rate elevation was suppressed in the E1 and E2 groups compared to the C group, and RPP after intubation significantly decreased in the E2 group compared to the C group. CONCLUSIONS: Esmolol injection, 1-2 mg/kg, prior to lightwand intubation effectively blunts heart rate elevation, and 2 mg/kg of esmolol injection blunts rate-pressure product elevation.
format Online
Article
Text
id pubmed-7724119
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Korean Society of Anesthesiologists
record_format MEDLINE/PubMed
spelling pubmed-77241192020-12-15 Dosing study of esmolol for reducing hemodynamic changes during lightwand intubation Kang, Jin Ku Yoo, Sie Hyeon Chung, Jin Hun Kim, Nan Seol Jung, Ho Soon Seo, Yong Han Chun, Hea Rim Gong, Hyung Yoon Son, Hee Dong Kim, A Joo Anesth Pain Med (Seoul) Anesthetic Pharmacology BACKGROUND: Lightwand is a convenient tool that can be used instead of a laryngoscope for intubation. Tracheal intubation causes direct stimulation of the larynx, drastically increasing hemodynamic values including blood pressure and heart rate. This study aims to identify the effect of different doses of esmolol on hemodynamic changes during lightwand intubation. METHODS: The study subjects included 140 patients who underwent general anesthesia for elective surgery. The patients were randomly divided into four groups (35 patients in each group). The ‘C’ group only received 20 ml of normal saline, while the ‘E0.5’, ‘E1’, and ‘E2’ groups received 20 ml of normal saline containing esmolol—0.5 mg/kg, 1 mg/kg, and 2 mg/kg, respectively, injected 2 min prior to intubation. The patients’ blood pressure, heart rate, and rate-pressure product were measured six times, before and after the intubation. RESULTS: The degree of heart rate elevation was suppressed in the E1 and E2 groups compared to the C group, and RPP after intubation significantly decreased in the E2 group compared to the C group. CONCLUSIONS: Esmolol injection, 1-2 mg/kg, prior to lightwand intubation effectively blunts heart rate elevation, and 2 mg/kg of esmolol injection blunts rate-pressure product elevation. Korean Society of Anesthesiologists 2020-10-30 2020-10-30 /pmc/articles/PMC7724119/ /pubmed/33329844 http://dx.doi.org/10.17085/apm.19067 Text en Copyright © the Korean Society of Anesthesiologists, 2020 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Anesthetic Pharmacology
Kang, Jin Ku
Yoo, Sie Hyeon
Chung, Jin Hun
Kim, Nan Seol
Jung, Ho Soon
Seo, Yong Han
Chun, Hea Rim
Gong, Hyung Yoon
Son, Hee Dong
Kim, A Joo
Dosing study of esmolol for reducing hemodynamic changes during lightwand intubation
title Dosing study of esmolol for reducing hemodynamic changes during lightwand intubation
title_full Dosing study of esmolol for reducing hemodynamic changes during lightwand intubation
title_fullStr Dosing study of esmolol for reducing hemodynamic changes during lightwand intubation
title_full_unstemmed Dosing study of esmolol for reducing hemodynamic changes during lightwand intubation
title_short Dosing study of esmolol for reducing hemodynamic changes during lightwand intubation
title_sort dosing study of esmolol for reducing hemodynamic changes during lightwand intubation
topic Anesthetic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724119/
https://www.ncbi.nlm.nih.gov/pubmed/33329844
http://dx.doi.org/10.17085/apm.19067
work_keys_str_mv AT kangjinku dosingstudyofesmololforreducinghemodynamicchangesduringlightwandintubation
AT yoosiehyeon dosingstudyofesmololforreducinghemodynamicchangesduringlightwandintubation
AT chungjinhun dosingstudyofesmololforreducinghemodynamicchangesduringlightwandintubation
AT kimnanseol dosingstudyofesmololforreducinghemodynamicchangesduringlightwandintubation
AT junghosoon dosingstudyofesmololforreducinghemodynamicchangesduringlightwandintubation
AT seoyonghan dosingstudyofesmololforreducinghemodynamicchangesduringlightwandintubation
AT chunhearim dosingstudyofesmololforreducinghemodynamicchangesduringlightwandintubation
AT gonghyungyoon dosingstudyofesmololforreducinghemodynamicchangesduringlightwandintubation
AT sonheedong dosingstudyofesmololforreducinghemodynamicchangesduringlightwandintubation
AT kimajoo dosingstudyofesmololforreducinghemodynamicchangesduringlightwandintubation